{"id":810566,"date":"2023-07-01T18:08:34","date_gmt":"2023-07-01T20:08:34","guid":{"rendered":"https:\/\/teknomers.com\/fr\/part-biontech-plus-de-200-demandes-de-dommages-et-interets-en-allemagne-contre-des-fabricants-de-vaccins\/"},"modified":"2023-07-01T18:08:38","modified_gmt":"2023-07-01T20:08:38","slug":"part-biontech-plus-de-200-demandes-de-dommages-et-interets-en-allemagne-contre-des-fabricants-de-vaccins","status":"publish","type":"post","link":"https:\/\/teknomers.com\/fr\/part-biontech-plus-de-200-demandes-de-dommages-et-interets-en-allemagne-contre-des-fabricants-de-vaccins\/","title":{"rendered":"Part BioNTech : Plus de 200 demandes de dommages et int\u00e9r\u00eats en Allemagne contre des fabricants de vaccins"},"content":{"rendered":"<p> <br \/>\n<\/p>\n<div>\n<p>Dans la perspective de la proc\u00e9dure en dommages-int\u00e9r\u00eats contre le fabricant de vaccins BioNTech devant un tribunal allemand \u00e0 partir de lundi, le minist\u00e8re allemand de la Sant\u00e9 a donn\u00e9 le nombre de demandes en dommages-int\u00e9r\u00eats en cours contre les fabricants de vaccins : il y en a plus de 200.<br \/><a rel=\"nofollow noopener\" class=\"btn-more\" target=\"_blank\" href=\"https:\/\/www.finanzen.ch\/nachrichten\/biontech-aktie-mehr-als-200-schadenersatzklagen-in-deutschland-gegen-impfstoffhersteller-1032421912\">Lire l&#8217;article complet de l&#8217;awp ici<\/a><\/p>\n<\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.finanzen.net\/nachricht\/aktien\/biontech-aktie-mehr-als-200-schadenersatzklagen-in-deutschland-gegen-impfstoffhersteller-12600075\" rel=\"nofollow noopener\" target=\"_blank\">ttn-fr-28<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dans la perspective de la proc\u00e9dure en dommages-int\u00e9r\u00eats contre le fabricant de vaccins BioNTech devant un tribunal allemand \u00e0 partir de lundi, le minist\u00e8re allemand de la Sant\u00e9 a donn\u00e9 le nombre de demandes en dommages-int\u00e9r\u00eats en cours contre les fabricants de vaccins : il y en a plus de 200.Lire l&#8217;article complet de l&#8217;awp [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":716612,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[108,22925,841,16758,133,6390,12287,5163,901,1609],"class_list":["post-810566","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finance","tag-allemagne","tag-biontech","tag-contre","tag-demandes","tag-des","tag-dommages","tag-fabricants","tag-interets","tag-part","tag-vaccins"],"_links":{"self":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/posts\/810566","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/comments?post=810566"}],"version-history":[{"count":0,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/posts\/810566\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/media\/716612"}],"wp:attachment":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/media?parent=810566"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/categories?post=810566"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/tags?post=810566"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}